Savant Capital LLC Buys New Position in Neogen Corporation $NEOG

Savant Capital LLC bought a new position in shares of Neogen Corporation (NASDAQ:NEOG) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 10,391 shares of the company’s stock, valued at approximately $50,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avanza Fonder AB boosted its position in shares of Neogen by 17.9% during the 2nd quarter. Avanza Fonder AB now owns 16,435 shares of the company’s stock valued at $79,000 after purchasing an additional 2,499 shares in the last quarter. Gabelli Funds LLC lifted its stake in Neogen by 9.5% during the first quarter. Gabelli Funds LLC now owns 63,500 shares of the company’s stock valued at $551,000 after purchasing an additional 5,500 shares during the last quarter. New York State Teachers Retirement System boosted its holdings in Neogen by 4.3% during the second quarter. New York State Teachers Retirement System now owns 134,066 shares of the company’s stock worth $641,000 after buying an additional 5,500 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Neogen by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company’s stock worth $1,125,000 after buying an additional 5,638 shares during the last quarter. Finally, Bank Pictet & Cie Europe AG increased its holdings in shares of Neogen by 6.4% in the second quarter. Bank Pictet & Cie Europe AG now owns 99,025 shares of the company’s stock valued at $473,000 after buying an additional 5,975 shares in the last quarter. 96.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on NEOG. CJS Securities started coverage on Neogen in a research note on Monday, September 29th. They set a “market perform” rating and a $10.00 price objective for the company. Zacks Research upgraded Neogen from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 20th. Piper Sandler set a $6.50 price target on Neogen and gave the stock a “neutral” rating in a research note on Thursday, October 16th. William Blair lowered shares of Neogen from an “outperform” rating to a “market perform” rating in a research note on Tuesday, July 29th. Finally, Wall Street Zen downgraded shares of Neogen from a “buy” rating to a “hold” rating in a research report on Sunday, November 9th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $8.83.

Neogen Trading Up 5.7%

Shares of NASDAQ NEOG opened at $5.72 on Friday. The company has a current ratio of 3.58, a quick ratio of 2.26 and a debt-to-equity ratio of 0.37. Neogen Corporation has a one year low of $3.87 and a one year high of $15.73. The business has a 50-day moving average price of $5.94 and a two-hundred day moving average price of $5.62. The firm has a market capitalization of $1.24 billion, a PE ratio of -1.19 and a beta of 1.90.

Neogen Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.